Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inovio Pharma (NQ: INO )

11.07 -0.81 (-6.82%)
Streaming Delayed Price Updated: 1:07 PM EDT, May 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharma

< Previous 1 2 3 4 5 6 7 8 Next >
Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine
Palm Beach, FL – October 20, 2021 – FinancialNewsMedia.com News Commentary – Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing... 
Via FinancialNewsMedia
Exposures COVID-19
Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage
Vaccine makers have been under tremendous selling pressure over the past 2 months driven by policy, the rising delta wave, and breakthrough infections. This slump has been a boost for the oral... 
Via Talk Markets
Analyzing Inovio Pharmaceuticals's Unusual Options Activity
Inovio Pharmaceuticals (NASDAQ:INO) shares experienced unus... 
Via Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
Exposures Product Safety
Is This The Turning Point for Inovio?
The biotech's streak of bad luck may be about to end, but risks remain. 
Via The Motley Fool
Exposures COVID-19
New Covid-19 Vaccines Continue to Be Developed by Biotech Firms Seeking to Improve the Jab
FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 6, 2021 – USA News Group – As vaccine passport programs continue to roll out in new markets across the globe, especially in... 
Via FinancialNewsMedia
Exposures COVID-19
Is Vaccine Latecomer Inovio Making a Comeback?
Its new plan for phase 3 trials is advancing. 
Via The Motley Fool
Exposures COVID-19
Looking Into Inovio Pharmaceuticals's Return On Capital Employed
Inovio Pharmaceuticals (NASDAQ:INO) brought in sales totaling $272.82 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 58.32%, resulting... 
Via Benzinga
Etsy And NetApp Lead The S&P 500
U.S. indices were trading lower Thursday as traders await signs of Fed tapering policy. Explosions outside of Kabul airport in Afghanistan has also caused macro uncertainty and... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
As the Virus Continues, the Global Covid-19 Vaccine Market Expected to Reach $25 Billion By 2024
Via FinancialNewsMedia
Exposures COVID-19
Why Inovio Stock Is Jumping Today
The vaccine maker received some good news from Brazil. 
Via The Motley Fool
Exposures COVID-19
Inovio Pharmaceuticals Stock Nears End Of Technical Pattern
Inovio Pharmaceuticals Inc. (NASDAQ:INO) shares are trading... 
Via Benzinga
Inovio To Start Global Late-Stage COVID-19 Vaccine Trial
The regulatory authority of Brazil has signed off Inovio Pharmaceuticals Inc's (NASDAQ: INO) global Phase 3 segment of its INNOVATE Phase 2/3 trial for INO-... 
Via Benzinga
Exposures COVID-19
Why Inovio's Stock Is Trading Higher Today
Inovio Pharmaceuticals Inc (NASDAQ: INO) is trading higher Thursday after the company announced it received regulatory authorization from Brazil's ANVISA to initiate the... 
Via Benzinga
2 Popular Robinhood Stocks I Wouldn't Buy With Free Money
Not every stock on the popular trading app is worth owning. 
Via The Motley Fool
Why Dynavax, Novavax, and Inovio Stocks Sank This Week
Investors appeared to be rattled by the U.S. government's decision to move forward with booster doses of mRNA vaccines. 
Via The Motley Fool
Exposures COVID-19
Unusual Options Activity Insight: Inovio Pharmaceuticals
On Wednesday, shares of Inovio Pharmaceuticals (NASDAQ:INO) saw unusual options activity. After the option alert, the stock price moved down to $8.29. Sentiment: BULLISH Option... 
Via Benzinga
3 Scary COVID Stocks to Avoid
Our Fool roundtable picks three COVID stocks they think are dangerous at these prices. 
Via The Motley Fool
Exposures COVID-19
77 Biggest Movers From Yesterday
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to... 
Via Benzinga
Apple And Salesforce Lead The DIA In A Mixed Day Of Trading
U.S. indices had a mixed day of trading Thursday as traders and investors weigh COVID-19 variant updates, recent earnings and the recently passed $1 trillion... 
Via Benzinga
Exposures COVID-19
Watch Out: Inovio Pharmaceuticals Is Heating Up
Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Thursday alongside other vaccine maker stocks. Stocks have been trading higher recently as the COVIS-19 delta... 
Via Benzinga
Why Inovio Pharmaceuticals Is Plunging Today
Solid business developments did not please investors. 
Via The Motley Fool
Exposures COVID-19
Why Inovio's Stock Is Trading Lower Today
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading lower by 9.9% at $8.65 after the company reported worse-than-expected second-quarter EPS and sales results.... 
Via Benzinga
Inovio Pharmaceuticals (INO) Q2 2021 Earnings Call Transcript
INO earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
85 Biggest Movers From Yesterday
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX... 
Via Benzinga
54 Stocks Moving In Tuesday's Mid-Day Session
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy... 
Via Benzinga
Recap: Inovio Pharmaceuticals Q2 Earnings
Shares of Inovio Pharmaceuticals (NASDAQ:INO) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 95.00% year... 
Via Benzinga
Why Inovio Stock Is Jumping Today
Chinese regulators approved the initiation of two new clinical studies featuring Inovio's COVID-19 vaccine candidate, INO-4800. 
Via The Motley Fool
Exposures COVID-19
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •... 
Via Benzinga
What Does the Delta Variant Mean for Inovio Pharmaceuticals' Stock?
Its vaccine candidate might be too far behind to matter. 
Via The Motley Fool
Exposures COVID-19
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.